Investing Center Preview – Manage your investments and watch your net worth grow.
AGN:NYSE – (Drugs - Generic)
Allergan plc – AGN Stock Overview
|Last Price||Today's Change||52-Week Range||Trading Volume|
|247.85||-1.13 (-0.45%)||195.50 - 340.34||2.2 million (Below Avg)|
Market data as of 4:00PM 07/25/16. Quotes are delayed by at least 15 min.
Overview - AGN
One-Click Scorecard - AGN
These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Performed well consistently?||Fail|
|Avoids excess debt?||Fail|
|Converting sales to profits?||Fail|
|Shareholder's money handled rationally?||Fail|
|Increased shareholder value?||Fail|
|Consistently increased owner earnings?||Pass|
|Sells at 25% discount to intrinsic value?||Fail|
These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Pays a cash dividend?||Fail|
|Room to increase dividends?||Fail|
|Increased earnings over time?||Fail|
|Borrows within reasonable limits?||Fail|
|Stock is undervalued?||Fail|
|Have investors caught on?||Pass|
|Has support of institutional investors?||Pass|
|Has sufficient liquidity?||Pass|
Latest Headlines - AGN
Allergan Receives Positive Opinion For Truberzi® (Eluxadoline) For Treatment Of Irritable Bowel Syndrome With Diarrhoea (IBS-D) In Adults
PR Newswire - Monday 07/25/2016 11:30 AM ET
Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'
Business Wire - Friday 07/22/2016 4:54 PM ET
Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With Trastuzumab In Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
PR Newswire - Thursday 07/21/2016 9:00 AM ET
Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB'
Business Wire - Wednesday 07/20/2016 12:09 PM ET
Actress Marisa Tomei Partners with Allergan to Raise Awareness of Chronic Dry Eye
PR Newswire - Wednesday 07/20/2016 7:59 AM ET
Allergan and Adamas Announce New Expanded Indication for NAMZARIC® (Memantine and Donepezil Hydrochlorides) Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease
PR Newswire - Tuesday 07/19/2016 7:59 AM ET
Allergan Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator
PR Newswire - Monday 07/18/2016 8:05 AM ET
Market Updates on Drugs - Generic Equities -- Mylan, Horizon Pharma, Allergan, and Diplomat Pharmacy
PR Newswire - Friday 07/15/2016 7:30 AM ET
Industry Position - AGN
|Revenue Growth (1yr)||21.83%|
|Net Income Growth (1yr)||--|